These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1759983)

  • 1. The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients.
    Cortellaro M; Boschetti C; Cofrancesco E; Zanussi C; Catalano M; de Gaetano G; Gabrielli L; Lombardi B; Specchia G; Tavazzi L
    Atherosclerosis; 1991 Oct; 90(2-3):109-18. PubMed ID: 1759983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
    Cortellaro M; Boschetti C; Cofrancesco E; Zanussi C; Catalano M; de Gaetano G; Gabrielli L; Lombardi B; Specchia G; Tavazzi L
    Arterioscler Thromb; 1992 Sep; 12(9):1063-70. PubMed ID: 1525121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Green D; Ruth KJ; Folsom AR; Liu K
    Arterioscler Thromb; 1994 May; 14(5):686-93. PubMed ID: 8172846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study.
    Wu KK; Folsom AR; Heiss G; Davis CE; Conlan MG; Barnes R
    Ann Epidemiol; 1992 Jul; 2(4):471-80. PubMed ID: 1342298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tibolone therapy on lipids and coagulation indices.
    Daher R; Al-Amin H; Beaini M; Usta I
    Clin Chem Lab Med; 2006; 44(12):1498-9. PubMed ID: 17163831
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of hemostatic factors with peripheral vascular disease.
    Philipp CS; Cisar LA; Kim HC; Wilson AC; Saidi P; Kostis JB
    Am Heart J; 1997 Nov; 134(5 Pt 1):978-84. PubMed ID: 9398113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
    Ossei-Gerning N; Wilson IJ; Grant PJ
    Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Folsom AR; Conlan MG; Davis CE; Wu KK
    Ann Epidemiol; 1992 Jul; 2(4):481-94. PubMed ID: 1342299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis.
    Vigna GB; Bolzan M; Romagnoni F; Valerio G; Vitale E; Zuliani G; Fellin R
    Circulation; 1992 Jun; 85(6):2205-11. PubMed ID: 1591837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lipoprotein(a) with atherothrombotic events and fibrinolytic variables. A case-control study.
    Franceschini G; Cofrancesco E; Safa O; Boschetti C; Tremoli E; Mussoni L; Sirtori CR; Cortellaro M
    Thromb Res; 1995 May; 78(3):227-38. PubMed ID: 7631303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study.
    Knuiman MW; Folsom AR; Chambless LE; Liao D; Wu KK
    Neuroepidemiology; 2001 May; 20(2):96-104. PubMed ID: 11359076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
    Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
    Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Folsom AR; Rosamond WD; Shahar E; Cooper LS; Aleksic N; Nieto FJ; Rasmussen ML; Wu KK
    Circulation; 1999 Aug; 100(7):736-42. PubMed ID: 10449696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
    Ridker PM; Stampfer MJ; Rifai N
    JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris.
    Thompson SG; Fechtrup C; Squire E; Heyse U; Breithardt G; van de Loo JC; Kienast J
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):357-62. PubMed ID: 8630659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolism.
    Dahl T; Kontny F; Slagsvold CE; Christophersen B; Abildgaard U; Odegaard OR; Morkrid L; Dale J
    Cerebrovasc Dis; 2000; 10(2):110-7. PubMed ID: 10686449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.
    Woodward M; Lowe GD; Rumley A; Tunstall-Pedoe H; Philippou H; Lane DA; Morrison CE
    Br J Haematol; 1997 Jun; 97(4):785-97. PubMed ID: 9217177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.